Literature DB >> 25284530

Prevalence of hepatitis B vaccination among oral health care personnel in Mysore city, India.

Veera Reddy, Darshana Bennadi1, Nandita Kshetrimayum, C V K Reddy, G Satish, Umashankar Kura, Guruprasad Yadavalli.   

Abstract

BACKGROUND: The transmission of blood borne virus in health care workers is a potential occupational hazard to patients as well as to the Oral Health Care Personnel (OHCP). Hepatitis B remains a serious threat to dental team. PATIENTS AND METHODS: To assess the vaccination status and post vaccination antibody status of oral health care personnel against Hepatitis B Virus (HBV) infection. Descriptive Cross-sectional questionnaire study was conducted among the oral health care personnel of Mysore city.
RESULTS: Out of 300 oral health care personnel 256 (85.4%) were vaccinated for HBV infection and 44 (14.6%) had not taken vaccination. Highest frequency of vaccination was seen among dentists and least amongst dental lab technicians and other workers. This difference was highly significant among the different occupation groups (p= 0.001).
CONCLUSION: Majority of the OHCP of Mysore city have been vaccinated. Among them, dentists formed the majority group of vaccinated. But there was ignorance and less awareness regarding Hepatitis B vaccination among dental lab technicians and other workers like dental assistants and cleaning staff. Awareness amongst OHCPS against Hepatitis B vaccination has increased significantly over the years, but there are few who do not intend to get vaccinated.

Entities:  

Year:  2014        PMID: 25284530

Source DB:  PubMed          Journal:  Oral Health Dent Manag        ISSN: 2247-2452


  2 in total

1.  Infection Control Measures in Private Dental Clinics in Lebanon.

Authors:  Jihad Dagher; Charles Sfeir; Ahmad Abdallah; Zeina Majzoub
Journal:  Int J Dent       Date:  2017-05-31

2.  Prevalence of hepatitis B, C, and HIV among patients attending a teaching dental hospital. A 7-year retrospective study from the United Arab Emirates.

Authors:  Suhail H Al-Amad
Journal:  Saudi Med J       Date:  2018-05       Impact factor: 1.484

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.